Invacare Revenue 2010-2023 | IVCRQ

Invacare revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Invacare Annual Revenue
(Millions of US $)
2022 $742
2021 $872
2020 $851
2019 $928
2018 $972
2017 $966
2016 $1,047
2015 $1,142
2014 $1,270
2013 $1,335
2012 $1,416
2011 $1,482
2010 $1,425
2009 $1,693
Invacare Quarterly Revenue
(Millions of US $)
2023-03-31 $165
2022-12-31 $181
2022-09-30 $170
2022-06-30 $189
2022-03-31 $201
2021-12-31 $226
2021-09-30 $224
2021-06-30 $226
2021-03-31 $196
2020-12-31 $224
2020-09-30 $212
2020-06-30 $196
2020-03-31 $218
2019-12-31 $233
2019-09-30 $236
2019-06-30 $236
2019-03-31 $223
2018-12-31 $245
2018-09-30 $245
2018-06-30 $246
2018-03-31 $237
2017-12-31 $250
2017-09-30 $251
2017-06-30 $234
2017-03-31 $232
2016-12-31 $247
2016-09-30 $268
2016-06-30 $275
2016-03-31 $258
2015-12-31 $283
2015-09-30 $284
2015-06-30 $286
2015-03-31 $289
2014-12-31 $318
2014-09-30 $321
2014-06-30 $327
2014-03-31 $305
2013-12-31 $322
2013-09-30 $337
2013-06-30 $345
2013-03-31 $331
2012-12-31 $326
2012-09-30 $362
2012-06-30 $373
2012-03-31 $355
2011-12-31 $131
2011-09-30 $457
2011-06-30 $466
2011-03-31 $428
2010-12-31 $154
2010-09-30 $437
2010-06-30 $431
2010-03-31 $402
2009-12-31 $449
2009-09-30 $434
2009-06-30 $413
2009-03-31 $398
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47